Clinical Trials Browser

Phase 1/2 × Lymphoma × Injections × Clear all

NCT06883526 2026-01-05

Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma

Phase 1/2 Recruiting

Lymphoma